Immune & inflammatory: new FDA approvals
Brand, generic name, approval date and the use the FDA approved it for. No recommendations. Updated 2026-10-12.
Weight loss & diabetesCancerBrain & mental healthInfections & vaccinesHeart & bloodImmune & inflammatoryKidney, liver & lungEyeWomen's & hormonal healthPain & anesthesiaDiagnostic & imaging agentsRare & geneticOther
LisrayaImmune & inflammatory
brepocitinib · Priovant TherapTo treat dermatomyositis in adultsIcotydeImmune & inflammatory
icotrokinra · Janssen BiotechTo treat moderate-to-severe plaque psoriasis in patients 12 years and older who weigh at least 40 kg and who are candidates for systemic therapy or phototherapyAdqueyImmune & inflammatory
difamilast · Acrotech BiopharmaTo treat mild to moderate atopic dermatitisYartemleaImmune & inflammatory
narsoplimab-wuug · Omeros CorpTo treat hematopoietic stem cell transplant-associated thrombotic microangiopathyExdensurImmune & inflammatory
depemokimab-ulaa · Glaxosmithkline LLCTo treat severe asthma characterized by an eosinophilic phenotype as an Komziftiadd-on maintenance therapyRhapsidoImmune & inflammatory
remibrutinib · NovartisTo treat chronic spontaneous urticaria in adults who remain symptomatic despite H1 antihistamine treatmentAnzupgoImmune & inflammatory
delgocitinib · Leo Pharma AsTo treat moderate-to-severe chronic hand eczema when topical corticosteroids are not advisable or produce an inadequate responseEbglyssImmune & inflammatory
lebrikizumab-lbkzTo treat moderate-to-severe atopic dermatitisNiktimvoImmune & inflammatory
axatilimab-csfrTo treat chronic graft-versus-host disease (cGVHD)NemluvioImmune & inflammatory
nemolizumab-ilto · Galderma Labs LpTo treat prurigo nodularisLeqselviImmune & inflammatory
deuruxolitinibTo treat severe alopecia areataOhtuvayreImmune & inflammatory
ensifentrine · MsdTo treat chronic obstructive pulmonary disease